Improving Adherence to Cervical Cancer Screening Guidelines

Jointly provided by Postgraduate Institute for Medicine and American Sexual Health Association. This activity is supported by an independent educational grant from Roche.
Release date: September 17, 2021
Expiration date: September 17, 2022
Estimated time to complete activity: .5 hours

Target Audience

This activity is intended for physicians, physician assistants, registered nurses and nurse practitioners engaged in the engaged in the care of women.

Educational Objectives

After completing this activity, the participant should be better able to:

Identify the primary evidence for cervical cancer screening recommendations from ACS
Compare ACS updates to guidelines from the USPSTF, ACOG and other major professional societies
Discuss the recommendation for HPV primary screening as well as barriers to implementing this screening strategy
Employ shared decision-making on cervical cancer screening

Faculty

Ina Park, MD
Associate Professor
Family Community Medicine
University of California
San Francisco School of Medicine

Rebecca B Perkins, MD, MSc
Associate Professor, Obstetrics and Gynecology
Boston University School of Medicine

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Ina Park, MD
Dr. Park has nothing to disclose.

Rebecca B Perkins, MD, MSc
Dr. Perkins has nothing to disclose.

The PIM planners and others have nothing to disclose. The American Sexual Health Association planners and others have nothing to disclose.

Pre-Test

Prior to listening to the podcast, take a quick pre-test to gauge your knowledge.

Listen

ASHA · Provider Education: Cervical Cancer Screening Guidelines

Method of Participation and Request for Credit

In order to obtain your CE certificate, please choose the appropriate link below at the conclusion of the activity. You will be able to print your certificate of credit after completing a brief evaluation and post-test.

For AMA credit (MDs and DOs)—click here
For AMA credit (Non-physician)—click here
For ANCC credit—click here

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and American Sexual Health Association. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is .5 contact hours.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.